Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

被引：0
|
作者：
Fujita, K. [1 ]
机构：
[1] Natl Hosp Org Kyoto Med Ctr, Resp Med, Kyoto, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3918
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Features of Microscopic Colitis in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Choi, Kati
    Abu-Sbeih, Hamzah
    Samdani, Rashmi
    Raju, Gottumukkala
    Richards, David
    Stroehlein, John
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S67 - S67
  • [32] Incidence of tuberculosis in advanced lung cancer patients treated with immune checkpoint inhibitors-A nationwide population-based cohort study
    Kim, Hyung Woo
    Kim, Ju Sang
    Lee, Sang Haak
    LUNG CANCER, 2021, 158 : 107 - 114
  • [33] Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
    Chen, Xiuqiong
    Li, Zhaona
    Zhou, Jing
    Wei, Qianhui
    Wang, Xinyue
    Jiang, Richeng
    PEERJ, 2022, 10
  • [34] Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
    Catalano, Martina
    Fancelli, Sara
    Caliman, Enrico
    Mazzoni, Francesca
    Michelet, Marta Gatta
    Mancini, Silvia
    Manneschi, Clara
    Shabani, Sonia
    Napolitano, Brunella
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, Sohee
    Kim, Ju Hwan
    Shin, Ju-Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (08) : 1291 - 1300
  • [36] Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors
    Castello, Angelo
    Rossi, Sabrina
    Toschi, Luca
    Lopci, Egesta
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [37] Delayed and posttreatment immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors
    Jacob, Saya
    Fisch, Samantha
    Face, Carolyn
    Huppert, Laura
    Quandt, Zoe
    Quintal, Laura
    Melisko, Michelle
    Majure, Melanie
    Chien, Jo
    Blaes, Anne
    Rugo, Hope
    CANCER RESEARCH, 2024, 84 (09)
  • [38] Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors.
    Jacob, Saya
    Quandt, Zoe
    Melisko, Michelle E.
    Majure, Melanie
    Chien, Amy Jo
    Blaes, Anne Hudson
    Heditsian, Diane
    Esserman, Laura
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] The incidence and risk of cardiovascular events among gastroesophageal cancer patients receiving immune-checkpoint inhibitors.
    Ibis, Betul
    Cakir Colak, Sena
    Banga, Akshat
    Song, Junmin
    Chi, Kuan-Yu
    Chang, Yu
    Chiang, Cho Han
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 374 - 374
  • [40] Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors
    Chute, Donald F.
    Zhao, Sophia
    Strohbehn, Ian A.
    Rusibamayila, Nifasha
    Seethapathy, Harish
    Lee, Meghan
    Zubiri, Leyre
    Gupta, Shruti
    Leaf, David E.
    Rahma, Osama
    Drobni, Zsofia D.
    Neilan, Tomas G.
    Reynolds, Kerry L.
    Sise, Meghan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (01) : 134 - 137
12345